To investigate whether the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood assay changes the diagnostic testing pattern in patients referred to a cardiologist for the evaluation of chest pain or anginal equivalent symptoms.
A prospective cohort of 88 subjects receiving the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay were compared to a retrospective cohort of 83 subjects that did not receive the assay.
Study Type
OBSERVATIONAL
Enrollment
171
Age/Sex/Gene Expression Score - ASGES
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Change in management practice pattern between preliminary and after Corus CAD (ASGES) decision
Change in management pattern comparing the preliminary and after Corus CAD (ASGES) decision will be measured by the number of subjects with medical management downgrade or upgrade within the following predefined categories: 1. No further cardiac testing or treatment 2. Medical therapy for angina or non-cardiac chest pain 3. Stress testing with or without imaging 4. CT angiography 5. Invasive cardiac catheterization
Time frame: Up to 7 days
Change in management practice pattern between after Corus CAD decision and historical cohort.
Change in management pattern comparing the Corus CAD (ASGES) driven decision and the historical cohort ill be measured by the number of subjects with medical management downgrade or upgrade within the following predefined categories: 1. No further cardiac testing or treatment 2. Medical therapy for angina or non-cardiac chest pain 3. Stress testing with or without imaging 4. CT angiography 5. Invasive cardiac catheterization
Time frame: up to 195 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.